Volume 1 · 2026
Peptide science · analytical quality · research policy
A NuLab Peptides Publication
NULAB
Research Journal
Peptide science · analytical quality · research policy
Research · Analysis · Perspective
Peptide research,
examined with context.
Reporting and practical education on the science, testing, and policy shaping peptide research.
Volume 1 · 2026Current EditionScience, Methods& Research PolicyView edition contents →
Current edition Inaugural Edition · 2026
Featured
-
Peptides Are Becoming More Mainstream. What Will Compounded Products Cost?
Peptides are gaining a broader pharmacy presence. NuLab Research Journal welcomes the direction and examines advertised prices, clinical fees and the gap with research-catalog listings.
-
GLOW, KLOW and Wolverine: What the New Peptide Compounding Policy Leaves Out
Does the new HHS peptide compounding policy cover GLOW, KLOW or Wolverine blends? Understand the single-ingredient rule and what the…
-
HHS Peptide Compounding Update 2026: What Changes for Six Peptides
HHS has released a draft enforcement-discretion policy covering six peptides. Here is what the October 2026 announcement changes, its conditions,…
Recently published
Newest first
-
Wolverine Stack: What BPC-157 and TB-500 Research Shows
A 2026 rat study tested BPC-157 and TB-500 together. Read what it found and why exact peptide identity and blend testing deserve close attention.
-
Eli Lilly’s Retatrutide Lawsuits Reach Beyond the Courtroom
Explore Eli Lilly’s August 2026 retatrutide lawsuits, its call to platforms, payment processors and shippers, and later court developments.
-
How to Verify a Peptide COA: Batch Numbers, Laboratory Lookups, Test Dates, and Product Match
A field-by-field method for checking whether a peptide COA actually belongs to the vial and batch being evaluated.
-
How to Store Peptides: Freezer vs. Refrigerator Guide
Most sealed lyophilized peptide vials can be frozen for long-term storage. Reconstituted peptide vials belong in the refrigerator, away from light.
-
MOTS-c Human Evidence: What Studies and the FDA Review Actually Show
MOTS-c has human observational research, extensive preclinical interest, and a new ongoing trial—but no completed published trial of administered native MOTS-c.
-
Is GHK-Cu FDA Approved? What the Upcoming FDA Review Actually Covers
FDA plans to review non-injectable GHK-Cu for possible inclusion on a pharmacy-compounding list. That is not drug approval—and it does not cover injectable use.
-
Retatrutide Phase 3 Results: What the 2026 Trials Found and Its Current FDA Status
A source-based review of the retatrutide Phase 3 results reported through July 31, 2026, what remains unpublished, and the difference between a planned FDA…
-
Is BPC-157 FDA Approved? What the July 2026 Vote Really Means
The July 2026 BPC-157 vote concerned pharmacy compounding—not FDA drug approval. Here is what changed, what did not, and what happens next.
Browse by subject
Journal departments
Science & Discovery
Methods, mechanisms, emerging platforms, and notable findings.
Quality & Testing
Analytical methods, identity, purity, COAs, and lot documentation.
Policy & Industry
Regulation, manufacturing, supply chains, and research standards.
Laboratory Practice
Storage, handling, procurement, recordkeeping, and research operations.
Editorial approach
Context before conclusions.
NuLab’s editorial team aims to explain what available evidence says, what it does not say, and why that distinction matters.
Traceable sources
Primary literature, government records, and original documentation are prioritized whenever available.
Defined article types
Analysis, Technical Guide, Research News, and Policy Brief labels tell readers what kind of material they are reading.
Visible updates
Publication dates, substantive revisions, and material corrections are made visible to readers.
Review NuLab quality documentation
Certificates of analysis and testing information, organized for research use.